D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.76% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
CALL
ZIM Integrated Shipping Services
ZIM
$2.97B
| $395K | ﹤0.01% |
40,000
-20,000
| -33% | -$168K |
|
|
JWN
3477
DELISTED
Nordstrom
JWN
| $395K | ﹤0.01% |
21,390
-432
| -2% | -$6.63K |
|
3478
Solid Power
SLDP
$484M
| $395K | ﹤0.01% |
272,076
+205,005
| +306% | +$307K |
|
3479
CALL
Dutch Bros
BROS
$8.97B
| $393K | ﹤0.01% |
+12,400
| New | +$338K |
|
|
IGMS
3480
DELISTED
IGM Biosciences
IGMS
| $393K | ﹤0.01% |
47,245
-28,669
| -38% | -$166K |
|
3481
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.67B
| $392K | ﹤0.01% |
+10,005
| New | +$359K |
|
3482
OGE Energy
OGE
$10.2B
| $392K | ﹤0.01% |
11,220
-44,010
| -80% | -$1.52M |
|
3483
CALL
Monster Beverage
MNST
$93.2B
| $392K | ﹤0.01% |
6,800
| – | – |
|
|
GAMB
3484
DELISTED
Gambling.com
GAMB
| $389K | ﹤0.01% |
+39,939
| New | +$464K |
|
3485
Chunghwa Telecom
CHT
$33.5B
| $389K | ﹤0.01% |
+9,966
| New | +$368K |
|
3486
PUT
Target Hospitality
TH
$1.55B
| $389K | ﹤0.01% |
40,000
| – | – |
|
|
FRGE
3487
DELISTED
Forge Global Holdings
FRGE
| $388K | ﹤0.01% |
+7,545
| New | +$320K |
|
3488
Provident Financial Services
PFS
$3.12B
| $388K | ﹤0.01% |
21,514
-88,996
| -81% | -$1.4M |
|
3489
Utz Brands
UTZ
$1.25B
| $387K | ﹤0.01% |
23,836
+9,136
| +62% | +$121K |
|
3490
Bank of Montreal
BMO
$124B
| $386K | ﹤0.01% |
3,900
-33,664
| -90% | -$2.81M |
|
3491
CubeSmart
CUBE
$9.53B
| $386K | ﹤0.01% |
+8,319
| New | +$327K |
|
3492
Worthington Enterprises
WOR
$2.79B
| $386K | ﹤0.01% |
6,700
-33,310
| -83% | -$1.46M |
|
3493
LXP Industrial Trust
LXP
$3.54B
| $384K | ﹤0.01% |
7,742
-66,861
| -90% | -$2.92M |
|
3494
PUT
Fortrea Holdings
FTRE
$1.84B
| $384K | ﹤0.01% |
11,000
| – | – |
|
3495
Dave & Buster's
PLAY
$356M
| $383K | ﹤0.01% |
7,107
-9,703
| -58% | -$393K |
|
3496
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.5B
| $382K | ﹤0.01% |
+11,644
| New | +$340K |
|
3497
PUT
TransAlta
TAC
$4.22B
| $380K | ﹤0.01% |
45,700
-44,300
| -49% | -$358K |
|
3498
Standex International
SXI
$3.67B
| $380K | ﹤0.01% |
2,399
| – | – |
|
3499
Utah Medical Products
UTMD
$219M
| $379K | ﹤0.01% |
4,504
-212
| -4% | -$17.6K |
|
3500
CALL
Teva Pharmaceuticals
TEVA
$36.2B
| $379K | ﹤0.01% |
36,300
| – | – |
|
Similar funds
D.E. Shaw & Co's Q4 2023 Portfolio in Review
As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
- D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
- D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.